• Presenting PALMO (Platform for Analyzing Longitudinal Multi-Omics), a comprehensive and modular framework designed to address these challenges
• By enabling high-resolution, time-aware insights into molecular dynamics, this platform provides a powerful tool for biomarker discovery, patient stratification, and therapeutic response monitoring in clinical and translational research, paving the way for improved therapeutic strategies and personalized medicine
SUHAS VASAIKAR, Associate Director, Pfizer
